Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences: Wells Fargo...
Wednesday, August 21, 2024 BiopharmaWatch Research 2 min read
Key Takeaway: Jazz Pharmaceuticals plc has announced its participation in upcoming investor conferences, specifically the Wells Fargo Healthcare Conference on September 4, 2024, and the Bank of America Global Healthcare Conference on September 18, 2024. The company will provide audio webcasts of the events, allowing investors to access the discussions conveniently. This initiative reflects Jazz's ongoing efforts to connect with the investment community and share insights about its business strategies and developments.
Price reaction · baseline $114.97 (2024-08-20 close) · hit after-hours · 1 other JAZZ headline(s) in the window, move may be shared
day 0 close · peak
-0.5%
Market Sentiment Analysis
POSITIVE FACTORS
Jazz Pharmaceuticals is participating in notable investor conferences.
The company showcases its commitment to investor engagement.
Webcasts will provide accessible information for investors.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+46%
120-day peak, hindsight
Typical move
2.1%
average across 9 past catalysts
Lead asset
GWP42004
Phase 2 · Diabetes Mellitus, Type 2
Full Press Release Details
DUBLIN , Aug. 21, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that Company management will participate in the following investor conferences:
Wells Fargo Healthcare Conference on Wednesday, September 4, 2024
Bank of America Global Healthcare Conference on Wednesday, September 18, 2024
Audio webcasts of the fireside chats will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations . A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Investors: Andrea N. Flynn , Ph.D. Vice President, Head, Investor Relations Jazz Pharmaceuticals plc [email protected] Ireland +353 1 634 3211 U.S. +1 650 496 2717
Frequently Asked Questions
When will Jazz Pharmaceuticals participate in investor conferences?
Jazz Pharmaceuticals will participate in the Wells Fargo Conference on September 4 and the Bank of America Conference on September 18, 2024.
Where can I find the audio webcasts of Jazz's conferences?
Audio webcasts can be accessed in the Investors section of Jazz Pharmaceuticals' website.
How long will the webcasts be available for replay?
The webcasts will be archived for 30 days on the Jazz Pharmaceuticals website.
What is the focus of Jazz Pharmaceuticals?
Jazz Pharmaceuticals focuses on developing life-changing medicines for serious diseases.
Where is Jazz Pharmaceuticals headquartered?
Jazz Pharmaceuticals is headquartered in Dublin, Ireland.